Comprehensive bioinformatics investigations have identified the SERPINA1 glycosylation gene as one of seven glycosylation genes associated with glioma prognosis, indicating its involvement in cytokine signaling, inflammatory responses, immunological control, glycan synthesis, and metabolic pathways. The gene discussed is SERPINA1; the disease is glioma.